Feasibility of de-escalating axillary surgery in patients with clinical N2–3, pathological N0 breast cancer after neoadjuvant chemotherapy

Feasibility of de-escalating axillary surgery in patients with clinical N2–3, pathological N0 breast cancer after neoadjuvant chemotherapy

Abstract Axillary lymph node dissection (ALND) omission improves quality of life but is only considered under certain conditions. We investigated expanding these conditions in patients receiving neoadjuvant chemotherapy (NAC) for clinical N2–3, pathological N0 breast cancer. We retrospectively revie...

Full description

Saved in:
Bibliographic Details
Main Authors: Ee Jin Kim, Tae Kyung Yoo, Jisun Kim, Il Yong Chung, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Sae Byul Lee
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Breast cancer
Neoadjuvant chemotherapy
Axillary lymph node dissection
Sentinel lymph node biopsy
Clinical N2-3
ALND omission
Online Access:https://doi.org/10.1038/s41598-024-84841-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-84841-y

Similar Items